Business
Universal Ibogaine Announces Approval for Trading on the OTCQB Venture Market
Universal Ibogaine Announces Approval for Trading on the OTCQB Venture Market C...
About this update from Universal Ibogaine Inc
[{"type":"text","content":"\n \n \n \n Universal Ibogaine Announces Approval for Trading on the OTCQB Venture Market\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n CALGARY, AB\n \n ,\n \n Feb. 28, 2022\n \n /CNW/ - Universal Ibogaine Inc. (TSXV:IBO ) (OTCQB: IBOGF) (\"\n \n UI\n \n \" or the \"\n \n Company\n \n \") a life sciences company with a mission to transform the world of addiction treatment through medicalized ibogaine and a state of the art ongoing care program, is pleased to announce that its common shares have been approved for trading on the OTCQB Venture Market (the \"\n \n OTCQB\n \n \") under the ticker \"\n \n IBOGF\n \n \".  UI will continue to trade in\n \n Canada\n \n on the TSX Venture Exchange under its current ticker symbol IBO.  The UI common shares trading in\n \n the United States\n \n have also been approved for DTC eligibility.\n \n \n \n \n \n \n \n \n \n The OTCQB Venture Market is for early stage and developing U.S. and international companies, which are current in their reporting and undergo an annual verification and management certification process.  Investors can find Real-Time quotes and market information for the Company on\n \n www.otcmarkets.com\n \n \n \n \n Universal Ibogaine CEO\n \n Nick Karos\n \n \n stated: \"Accessing the vast\n \n USA\n \n market of retail and institutional investors  through the OTC platform will provide our current and future shareholders enhanced liquidity and expanded global exposure for the Company, which will assist with our future financing and growth plans.  We look forward to working with the OTC Markets Group, as the\n \n USA\n \n is a key future addiction treatment market for us, with over 100,000 lives lost to opioid overdose last year alone.\"\n \n \n \n OTC Markets Group Inc.\n \n operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 11,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, it connects a diverse network of broker-dealers that provide liquidity and execution servic...